

Name | Size/Type | Description | Date |
---|---|---|---|
Cabazitaxel consent | 113KB PDF | Cabazitaxel consent | 21 Apr 2020 |
Cabozantinib consent | 113KB PDF | Cabozantinib consent | 22 Dec 2020 |
Caelyx (Liposomal Doxorubicin) consent | 113KB PDF | Caelyx (Liposomal Doxorubicin) consent | 21 Apr 2020 |
Caelyx & Carboplatin consent | 113KB PDF | Caelyx & Carboplatin consent | 21 Apr 2020 |
CAP consent | 113KB PDF | CAP consent | 21 Apr 2020 |
Capecitabine + MMC consent | 116KB PDF | Capecitabine + MMC consent | 01 Dec 2020 |
Capecitabine + Streptozocin consent | 116KB PDF | Capecitabine + Streptozocin consent | 01 Dec 2020 |
Capecitabine + Temozolomide consent | 115KB PDF | Capecitabine + temozolomide consent | 01 Dec 2020 |
Capecitabine consent | 115KB PDF | Capecitabine consent | 01 Dec 2020 |
Carboplatin & Etoposide consent | 112KB PDF | Carboplatin & Etoposide consent | 21 Apr 2020 |
Carboplatin + 5FU consent | 117KB PDF | Carboplatin + 5FU consent | 13 Apr 2021 |
Carboplatin + Capecitabine consent | 137KB PDF | Carboplatin + Capecitabine consent | 01 Dec 2020 |
Carboplatin consent | 111KB PDF | Carboplatin consent | 21 Apr 2020 |
CAV consent | 112KB PDF | CAV consent | 21 Apr 2020 |
Cemiplimab consent | 112KB PDF | Cemiplimab consent | 21 Apr 2020 |
Ceritinib consent | 111KB PDF | Ceritinib consent | 21 Apr 2020 |
Cetuximab & Encorafenib consent | 114KB PDF | Cetuximab & Encorafenib consent | 20 Aug 2020 |
Cetuximab + Irinotecan MdG consent | 116KB PDF | Cetux + Folfiri consent | 01 Dec 2020 |
Cetuximab + Oxaliplatin MdG (Folfox) consent | 117KB PDF | Cetux + Folfox consent | 01 Dec 2020 |
Cetuximab, Carboplatin + 5FU consent | 118KB PDF | Cetuximab, Carboplatin + 5FU consent | 13 Apr 2021 |
Cetuximab, Cisplatin + 5FU consent | 118KB PDF | Cetuximab, Cisplatin + 5FU consent | 14 Apr 2021 |
Cisplatin & Etoposide consent | 112KB PDF | Cisplatin & Etoposide consent | 21 Apr 2020 |
Cisplatin + 5FU consent | 116KB PDF | Cisplatin + 5FU consent | 01 Dec 2020 |
Cisplatin + Capecitabine consent | 137KB PDF | Cisplatin + Capecitabine consent | 01 Dec 2020 |
Cisplatin consent | 111KB PDF | Cisplatin consent | 21 Apr 2020 |
Crizotinib consent | 111KB PDF | Crizotinib consent | 21 Apr 2020 |
Cyclophosphamide oral consent | 110KB PDF | Cyclophosphamide oral consent | 21 Apr 2020 |
All consent forms on this website are for the use of St Luke’s Cancer Alliance staff in respect of St Luke’s Cancer Alliance patients only.
For those who do not work within St Luke’s Cancer Alliance:
Use of this site and any information on it is at your own risk. We do not accept responsibility for the use of any information that may be set out on the website. You assume full responsibility for the use of the information. You may wish to take your own legal advice before using any of the consent forms.
Please note that the consent forms below are not tumour-specific; one consent form may be used to consent patients for more than one St Luke’s Alliance chemotherapy protocol which uses the same combination of chemotherapy.
These consent forms should act as an aide-memoire to health professionals and patients, by providing a check-list of the kind of information which patients should be offered, and by enabling the patient to have a written record of the main points discussed.
The relevant Macmillan leaflet(s) should also be provided to each patient before consent. In no way should written information given to the patient be regarded as a substitute for face-to-face discussions with the patient.
These consent forms are for solid tumour chemotherapy only, and are NOT to be used for chemo-radiotherapy regimens.